TY - JOUR
T1 - Cellular basis for rheumatoid inflammation
AU - Cush, J. J.
AU - Lipsky, P. E.
PY - 1991
Y1 - 1991
N2 - Rheumatoid arthritis (RA) is a chronic idiopathic disease characterized by persistent inflammation of the synovium, local destruction of bone and cartilage, and a variety of systemic manifestations. Although the etiologic stimulus has not been identified, rheumatoid synovitis is characterized by persistent immunologic activity, with CD4(+)/CD29(+) memory T cells prominently involved. Many of the local and systemic manifestations of RA appear to result from the production of a variety of cytokines within the inflamed synovium. A number of other inflammatory mediators produced in the rheumatoid synovium, including arachidonic acid metabolites, vasoactive amines, platelet-activating factor, and complement cleavage products contribute to the inflammatory process. In addition, the local production of immunoglobulin and the autoantibody, rheumatoid factor, along with the local production of immune complexes and complement activation, play a major role in the destructive potential of rheumatoid synovitis. The driving force behind rheumatoid inflammation, however, is likely to be CD4(+) T cells responding to an antigenic epitope in the synovium in an HLA-DR restricted manner. Understanding the immunopathogenic process underlying rheumatoid inflammation should provide insight into approaches to control the disease effectively and specifically.
AB - Rheumatoid arthritis (RA) is a chronic idiopathic disease characterized by persistent inflammation of the synovium, local destruction of bone and cartilage, and a variety of systemic manifestations. Although the etiologic stimulus has not been identified, rheumatoid synovitis is characterized by persistent immunologic activity, with CD4(+)/CD29(+) memory T cells prominently involved. Many of the local and systemic manifestations of RA appear to result from the production of a variety of cytokines within the inflamed synovium. A number of other inflammatory mediators produced in the rheumatoid synovium, including arachidonic acid metabolites, vasoactive amines, platelet-activating factor, and complement cleavage products contribute to the inflammatory process. In addition, the local production of immunoglobulin and the autoantibody, rheumatoid factor, along with the local production of immune complexes and complement activation, play a major role in the destructive potential of rheumatoid synovitis. The driving force behind rheumatoid inflammation, however, is likely to be CD4(+) T cells responding to an antigenic epitope in the synovium in an HLA-DR restricted manner. Understanding the immunopathogenic process underlying rheumatoid inflammation should provide insight into approaches to control the disease effectively and specifically.
UR - http://www.scopus.com/inward/record.url?scp=0026342665&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026342665&partnerID=8YFLogxK
U2 - 10.1097/00003086-199104000-00003
DO - 10.1097/00003086-199104000-00003
M3 - Article
C2 - 2009681
AN - SCOPUS:0026342665
SN - 0009-921X
VL - 265
SP - 9
EP - 22
JO - Clinical orthopaedics and related research
JF - Clinical orthopaedics and related research
ER -